跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
邱 淳志
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學臺北心臟醫學研究中心
https://orcid.org/0000-0002-5326-0514
電子郵件
17257
s.tmu.edu
tw
h-index
512
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2025
每年研究成果
概覽
指紋
網路
研究成果
(32)
類似的個人檔案
(7)
指紋
查看啟用 Chun-Chih Chiu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Influenza Vaccination
100%
Cohort Analysis
91%
Hazard Ratio
65%
Atrial Fibrillation
36%
Chronic Kidney Disease
36%
Apoplexy
32%
Lung Cancer
28%
Chronic Obstructive Pulmonary Disease
26%
Gout
26%
Patient with Hypertension
19%
Heart Ventricle Arrhythmia
17%
Liver Cancer
17%
Randomized Controlled Trial
17%
Antithrombotic
17%
Influenza Vaccine
12%
Deep Vein Thrombosis
12%
Cardiovascular System
11%
Diabetes Mellitus
10%
Maturity Onset Diabetes of the Young
10%
Cancer Risk
10%
Meta-Analysis
9%
Cerebral Hemorrhage
9%
Vascular Dementia
8%
CHADS2 Score
8%
Renal Replacement Therapy
8%
Patient with Type 2 Diabetes
8%
Endothelial Progenitor Cell
8%
Colorectal Cancer
8%
Atrial Flutter
8%
Contrast-Induced Nephropathy
8%
Alzheimer's Disease
8%
Side Effect
8%
Artery Calcification
8%
Pulse Wave Velocity
8%
COVID-19
8%
Acute Coronary Syndrome
8%
Venous Thromboembolism
8%
Arterial Thromboembolism
8%
Vitamin K Antagonist
8%
Proportional Hazards Model
8%
Warfarin
6%
Brain Ischemia
6%
Diabetes
6%
Drug Therapy
6%
Risk Reduction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
90%
Cohort Study
74%
Atrial Fibrillation
50%
Chronic Kidney Failure
36%
Chronic Obstructive Lung Disease
28%
Randomized Controlled Trial
28%
Lung Cancer
26%
Diabetes Mellitus
26%
Anticoagulant Agent
26%
Heart Failure
20%
Influenza Vaccine
20%
Gout
17%
Heart Ventricle Arrhythmia
17%
Alzheimer's Disease
17%
Brain Hemorrhage
17%
Comorbidity
17%
Brain Ischemia
13%
Antidiabetic Agent
10%
Liver Cancer
10%
Warfarin
10%
Non Insulin Dependent Diabetes Mellitus
9%
Multiinfarct Dementia
8%
Contrast Induced Nephropathy
8%
Heart Atrium Flutter
8%
Colorectal Cancer
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Venous Thromboembolism
8%
Antivitamin K
8%
Direct Oral Anticoagulant
8%
Elimination
8%
Arterial Thromboembolism
8%
Acute Heart Failure
5%
Nursing and Health Professions
Confidence Interval
27%
Influenza Vaccination
26%
Hazard Ratio
21%
Atrial Fibrillation
17%
Cohort Analysis
10%
Vaccination Policy
10%
Chronic Kidney Failure
9%
Cell Level
8%
Patient with Type 2 Diabetes
8%
Patient with Hypertension
8%
Obstructive Lung Disease
8%
Contrast Induced Nephropathy
8%
Renal Replacement Therapy
8%
CHADS2 Score
8%
Diabetes Mellitus
8%
Multiinfarct Dementia
8%
Heart Atrium Flutter
8%
Alzheimer's Disease
8%
Anticoagulant Agent
8%
Antivitamin K
8%
Brain Hemorrhage
6%
National Health Insurance
5%
